Vimarsana
Biggest News Aggregation in the World

Page 19 - Advaxis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advaxis Inc Today - Breaking & Trending Today

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, AYLA, SPNE, OFIX - Vimarsana News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, AYLA, SPNE, OFIX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of Ayala Pharmaceuticals, Inc. - Vimarsana News

EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of Ayala Pharmaceuticals, Inc.

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of Ayala Pharmaceuticals, Inc. - Vimarsana News

EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of Ayala Pharmaceuticals, Inc.

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

Delaware oncology company to merge with Princeton's Advaxis - Vimarsana News

Delaware oncology company to merge with Princeton's Advaxis

Ayala Pharmaceuticals and Princeton-based biotech firm Advaxis Inc. have entered into a definitive merger agreement.

Source: njbiz.com
Advaxis, Inc.: Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement - Vimarsana News

Advaxis, Inc.: Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement

Merger brings U.S. management and presence, cash to develop compelling late-stage asset Lead candidate AL102 being evaluated in ongoing Phase 2/3 RINGSIDE study, a potential registration trial in desmoid